세계의 디지털 헬스 시장 : 제공별, 질환별, 사용 사례별, 최종사용자별, 지역별 - 예측(-2030년)

The global digital health market is projected to reach USD 573.5 billion by 2030 from USD 199.1 billion in 2025, at a high CAGR of 23.6% during the forecast period.

The market is advancing steadily, propelled by the increasing demand for value-based care, the rising burden of chronic diseases, and a growing emphasis on preventive healthcare. With aging populations and escalating healthcare costs, providers and payers are turning to digital tools to improve care outcomes while optimizing resource utilization.

Solutions such as remote patient monitoring, digital therapeutics, and mobile health apps are playing a critical role in enabling continuous, at-home care, especially for chronic conditions like diabetes, hypertension, and heart disease. The market is further supported by expanding insurance coverage for digital interventions, strong consumer interest in health tracking, and innovation from both medtech and big tech players. Despite this momentum, the sector faces persistent challenges, chief among them are concerns over data security and privacy, regulatory uncertainty for emerging digital therapeutics, and the digital divide that limits access for elderly and low-income populations. These barriers must be addressed to fully realize the potential of digital health in delivering scalable, equitable, and high-quality care.

"Mental & behavioral health under the disease segment is expected to register the fastest growth during the forecast period."

In 2024, mental & behavioral health emerged as the fastest-growing segment of the digital health market. This is due to the rising awareness of mental well-being, increasing prevalence of stress, anxiety, and depression, and the reduced stigma around seeking help. The expansion of telepsychiatry, therapy apps, and AI-driven mental health platforms provides accessible, affordable, and confidential support, while integration with wearable devices and remote monitoring allows real-time tracking of behavioral patterns. These factors, combined with employer wellness programs and supportive healthcare policies, are driving rapid adoption and market expansion in this segment.

"The patients & consumers segment is projected to dominate the digital health market, by end user, during the forecast period."

In 2024, patients & consumers was the fastest-growing end-user segment in the digital health market. This is because of increasing health awareness, rising smartphone and wearable adoption, and the demand for personalized, on-demand healthcare solutions. Digital health apps, telemedicine platforms, and remote monitoring tools empower individuals to actively manage their health, access care anytime, and track vital signs or lifestyle metrics in real time. The shift toward preventive care, convenience-focused healthcare delivery, and self-management of chronic conditions has made patients and consumers the most dynamic growth driver in the market.

"Asia Pacific to witness the highest growth rate during the forecast period."

The Asia Pacific region is expected to register the fastest growth in the digital health market over the forecast period. Government initiatives promoting telemedicine, electronic health records, and AI-driven healthcare, combined with rising healthcare investments and expanding private sector participation, are accelerating adoption. Companies such as Halodoc (Indonesia) raised USD 100 million (in 2023), bringing its total to USD 258 million, with over 20 million monthly users on its platform. Government-led initiatives such as India's Ayushman Bharat Digital Mission (ABDM) is building a national digital health infrastructure, spanning EHRs, citizen health IDs, and analytics. In addition, strong private sector participation, increasing venture capital investments, and strategic partnerships between technology companies and healthcare providers are fueling innovation.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The break-down of primary interviews is as mentioned below:

• By Company Type - Tier 1: 31%, Tier 2: 28%, and Tier 3: 41%
• By Designation - C-level: 31%, Director-level: 25%, and Others: 44%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Digital Health Market

The key players operating in the digital health market include Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), Fitbit (US), Dexcom, Inc. (US), Boston Scientific Corporation (US), Masimo (US), Teladoc Health, Inc. (US), American Well (US), Hims & Hers Health, Inc. (US), Headspace (US), Noom, Inc. (US), Cerebral Inc. (US), Epic System Corporation (US), Omada Health Inc. (US), ORACLE (US), Click Therapeutics (US), Welldoc, Inc. (US), EverlyWell (US), TruDoc Healthcare LLC (UAE), CareSimple Inc. (US), VivaLNK, Inc. (US), Biobeat (Israel), and Virtual Therapeutics Corp. (US).

Research Coverage:

The report analyzes the digital health market and aims to estimate the market size and future growth potential of various market segments, based on offering, disease, use case, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

• Analysis of key drivers (Increasing penetration of smartphones, tablets, and other mobile platforms, Rising geriatric population and subsequent increase in prevalence of chronic diseases, Rising focus on patient-centric healthcare solutions, Increase in the use of wearables, Advancements in Al, Sensors & Connectivity (5G and 6G), Growth of Al-Powered Virtual Assistants and Chatbots), restraints (Interoperability issues, Low Digital Literacy in Certain Demographics), opportunities (Shift toward intelligent health ecosystem to deliver personalized health experiences, Increasing shift towards outpatient care model, Improving regulatory support and reimbursements, Advancements in digital health), and challenges (Clinical Validation & Long-Term Efficacy, Data Privacy and security concerns) influencing the growth of the digital health market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the digital health market
• Market Development: Comprehensive information on the lucrative emerging markets, components, deployments, technologies, applications, end users, and regions
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital health market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players, like Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), and Apple Inc. (US), in the digital health market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary interviews
    • 2.1.2.2 Insights from primary experts
    • 2.1.2.3 Breakdown of primary sources
• 2.2 RESEARCH METHODOLOGY
• 2.3 MARKET SIZE ESTIMATION
• 2.4 DATA TRIANGULATION
• 2.5 MARKET RANKING ANALYSIS
• 2.6 RISK ASSESSMENT
• 2.7 STUDY ASSUMPTIONS
• 2.8 LIMITATIONS
  • 2.8.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 DIGITAL HEALTH MARKET OVERVIEW
• 4.2 NORTH AMERICA: DIGITAL HEALTH MARKET, BY END USER AND COUNTRY
• 4.3 DIGITAL HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 DIGITAL HEALTH MARKET: REGIONAL MIX
• 4.5 DIGITAL HEALTH MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms
    • 5.2.1.2 Rising geriatric population and subsequent increase in prevalence of chronic diseases
    • 5.2.1.3 Rising focus on patient-centric healthcare solutions
    • 5.2.1.4 Rising use of wearables
    • 5.2.1.5 Advancements in AI, sensors, and connectivity (5G and 6G)
    • 5.2.1.6 Growth of AI-powered virtual assistants and chatbots
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Low digital literacy in certain demographics
    • 5.2.2.2 Interoperability issues
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Shift toward intelligent health ecosystem to deliver personalized health experiences
    • 5.2.3.2 Increasing shift towards outpatient care
    • 5.2.3.3 Improving regulatory support and reimbursements
    • 5.2.3.4 Advancements in digital health
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Healthcare gap in emerging economies
    • 5.2.4.2 Privacy and security concerns
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.4 INDUSTRY TRENDS
  • 5.4.1 EMERGENCE OF VALUE-BASED STRATEGY FOR CONTINUOUS CARE
  • 5.4.2 HOME: NEW HEALTHCARE HUB
  • 5.4.3 TECHNOLOGICALLY ENABLED PRIMARY CARE SERVICES
  • 5.4.4 RISING AWARENESS OF DIGITAL THERAPEUTICS TO TREAT HUMAN DISEASES
  • 5.4.5 SURGE IN MHEALTH APPS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 mHealth apps
    • 5.7.1.2 Wearable sensors & devices
    • 5.7.1.3 Remote patient monitoring
    • 5.7.1.4 Digital therapeutics
    • 5.7.1.5 Telehealth/virtual care platforms
    • 5.7.1.6 AI-powered tools
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Cloud computing & edge processing
    • 5.7.2.2 Data analytics & visualization
    • 5.7.2.3 Bluetooth & IoT connectivity
    • 5.7.2.4 EHR integration
  • 5.7.3 ADJACENT TECHNOLOGIES
    • 5.7.3.1 Digital twins
    • 5.7.3.2 AR/VR & extended reality (XR)
    • 5.7.3.3 Voice assistants/smart speakers
• 5.8 TARIFF AND REGULATORY ANALYSIS
  • 5.8.1 TARIFF DATA FOR HS CODE 9018
  • 5.8.2 TARIFF DATA FOR HS CODE 9021
  • 5.8.3 TARIFF DATA FOR HS CODE 8517
  • 5.8.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8.5 REGULATORY FRAMEWORK
• 5.9 PRICING ANALYSIS
  • 5.9.1 INDICATIVE PRICE, BY OFFERING
  • 5.9.2 INDICATIVE PRICE, BY REGION
• 5.10 PORTER'S FIVE FORCES ANALYSIS
  • 5.10.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10.2 BARGAINING POWER OF BUYERS
  • 5.10.3 THREAT OF SUBSTITUTES
  • 5.10.4 THREAT OF NEW ENTRANTS
  • 5.10.5 BARGAINING POWER OF SUPPLIERS
• 5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.11.2 BUYING CRITERIA
• 5.12 PATENT ANALYSIS
  • 5.12.1 PATENT PUBLICATION TRENDS FOR DIGITAL HEALTH MARKET
  • 5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL HEALTH
  • 5.12.3 MAJOR PATENTS IN DIGITAL HEALTH MARKET
• 5.13 UNMET NEEDS AND END-USER EXPECTATIONS
  • 5.13.1 UNMET NEEDS IN DIGITAL HEALTH MARKET
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES AND EVENTS
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 CASE STUDY 1: CLINICAS DEL AZUCAR (CDA)
  • 5.15.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM
  • 5.15.3 CASE STUDY 3: APPLE & NHS TEAMS
• 5.16 DIGITAL HEALTH MARKET: INVESTMENT LANDSCAPE AND FUNDING SCENARIO
• 5.17 TRADE ANALYSIS
  • 5.17.1 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 8518)
  • 5.17.2 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9021)
  • 5.17.3 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9022)
  • 5.17.4 TRADE ANALYSIS FOR DIGITAL HEALTH DEVICES (HSN CODE 9018)
• 5.18 DIGITAL HEALTH MARKET BUSINESS MODELS
  • 5.18.1 SUBSCRIPTION-BASED MODELS
  • 5.18.2 SOFTWARE AS A SERVICE (SAAS)/PLATFORM AS A SERVICE (PAAS)
  • 5.18.3 FREEMIUM MODELS WITH TIERED ACCESS
  • 5.18.4 OUTCOMES-BASED AND VALUE-BASED MODELS
• 5.19 IMPACT OF AI/GEN AI IN DIGITAL HEALTH MARKET
  • 5.19.1 KEY USE CASES
  • 5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
    • 5.19.2.1 Artificial intelligence in public health
    • 5.19.2.2 Artificial intelligence in digital health-issues and dimensions of ethical concerns
  • 5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.19.3.1 Telehealth and telemedicine
    • 5.19.3.2 Wearable devices
    • 5.19.3.3 Remote patient monitoring (RPM)
    • 5.19.3.4 Mobile health (mHealth)
  • 5.19.4 USER READINESS & IMPACT ASSESSMENT
    • 5.19.4.1 User readiness
      • 5.19.4.1.1 User A: Healthcare providers
      • 5.19.4.1.2 User B: Healthcare payers
      • 5.19.4.1.3 User C: Patients & consumers
      • 5.19.4.1.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs)
      • 5.19.4.1.5 User E: Other end users (academic institutes, research centers, government bodies)
    • 5.19.4.2 Impact assessment
      • 5.19.4.2.1 User A: Healthcare providers
        • 5.19.4.2.1.1 Implementation
        • 5.19.4.2.1.2 Impact
      • 5.19.4.2.2 User B: Healthcare payers
        • 5.19.4.2.2.1 Implementation
        • 5.19.4.2.2.2 Impact
      • 5.19.4.2.3 User C: Patients & consumers
        • 5.19.4.2.3.1 Implementation
        • 5.19.4.2.3.2 Impact
      • 5.19.4.2.4 User D: Pharmaceutical, biotech, and MedTech companies (including CROs)
        • 5.19.4.2.4.1 Implementation
        • 5.19.4.2.4.2 Impact
      • 5.19.4.2.5 User E: Other end users (academic institutes, research centers, government bodies)
        • 5.19.4.2.5.1 Implementation
        • 5.19.4.2.5.2 Impact
• 5.20 IMPACT OF 2025 US TARIFFS-DIGITAL HEALTH MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 KEY TARIFF RATES
  • 5.20.3 PRICE IMPACT ANALYSIS
  • 5.20.4 IMPACT ON COUNTRIES/REGIONS
    • 5.20.4.1 US
  • 5.20.5 EUROPE
  • 5.20.6 ASIA PACIFIC
  • 5.20.7 IMPACT ON END-USE INDUSTRIES
    • 5.20.7.1 Healthcare providers
    • 5.20.7.2 Healthcare payers
    • 5.20.7.3 Patients and consumers
    • 5.20.7.4 Pharmaceutical, biotechnology, and MedTech companies
    • 5.20.7.5 Other end users
• 5.21 REIMBURSEMENT ANALYSIS
• 5.22 RISK FACTORS AND MARKET ENTRY BARRIERS
• 5.23 FUTURE OUTLOOK AND DISRUPTION SCENARIOS

6 DIGITAL HEALTH MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 HARDWARE
  • 6.2.1 SMART HARDWARE SOLUTIONS VITAL IN POWERING DIGITAL HEALTH
  • 6.2.2 WEARABLES
    • 6.2.2.1 Wearables to empower patients with real-time health monitoring
  • 6.2.3 CONSUMER-GRADED WEARABLE HEALTHCARE DEVICES
    • 6.2.3.1 Wearable healthcare devices to empower consumers to be proactive about their well-being
  • 6.2.4 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES
    • 6.2.4.1 Clinical-grade devices to allow remote care with continuous monitoring
  • 6.2.5 IMPLANTABLE DEVICES
    • 6.2.5.1 Real-time data transmission to healthcare providers for proactive intervention and personalized care
  • 6.2.6 HANDHELD & PORTABLE DEVICES
    • 6.2.6.1 Compact design and integration with mobile health applications to make them highly effective for use in remote care
  • 6.2.7 STATIONARY DEVICES
    • 6.2.7.1 Stationary devices to be upgraded with IoT integration, AI-driven analytics, and cloud-enabled interoperability
• 6.3 SOLUTIONS/APPLICATIONS
  • 6.3.1 TELEHEALTHCARE/TELEMEDICINE
    • 6.3.1.1 Demand to advance connected care via virtual health platforms
  • 6.3.2 REMOTE PATIENT MONITORING
    • 6.3.2.1 Expected to be more seamlessly integrated with telemedicine platforms, expanding their capabilities
  • 6.3.3 VIRTUAL CARE & VIDEO CONSULTATION
    • 6.3.3.1 Offering enhanced efficiency, accessibility, and accuracy in remote healthcare, assisting in triaging patients and automating documentation
  • 6.3.4 VIRTUAL SITTING & NURSING PLATFORMS
    • 6.3.4.1 Offering remote patient monitoring with bidirectional communication
• 6.4 MHEALTH APPS
  • 6.4.1 TRANSFORMING CARE DELIVERY WITH MOBILE HEALTH SOLUTIONS
• 6.5 DIGITAL THERAPEUTICS
  • 6.5.1 EMPOWERING HEALTH BY COMBINING REAL-TIME DATA COLLECTION, PATIENT ENGAGEMENT TOOLS, AND INTEGRATION WITH HEALTHCARE PROVIDERS' SYSTEMS
• 6.6 DIGITAL PHARMACY & MEDICATION ACCESS
  • 6.6.1 ENHANCING MEDICATION ACCESS BY REACHING RURAL OR UNDERSERVED POPULATIONS, REDUCING TRAVEL AND WAIT TIMES, AND IMPROVING CONTINUITY OF CARE
• 6.7 DIGITAL DIAGNOSTICS & AT-HOME TESTING
  • 6.7.1 MOSTLY USED IN GLUCOSE MONITORING AND OTHER INFECTIOUS DISEASE TESTS, CHOLESTEROL AND LIPID PANELS, GENETIC TESTING, AND HORMONE OR FERTILITY ASSESSMENTS
• 6.8 PATIENT PORTALS
  • 6.8.1 PERSONALIZED HEALTH CONTENT, APPOINTMENT REMINDERS, AND SECURE MESSAGING AIM TO IMPROVE PATIENT ENGAGEMENT AND CARE COORDINATION
• 6.9 OTHER DIGITAL HEALTH SOLUTIONS/APPLICATIONS

7 DIGITAL HEALTH MARKET, BY DISEASE

• 7.1 INTRODUCTION
• 7.2 DIABETES
  • 7.2.1 INTEGRATING AI IN DIGITAL HEALTH TO CATER TO DIABETIC PATIENTS
• 7.3 CARDIOLOGY
  • 7.3.1 OFFERING EARLIER DETECTION, CONTINUOUS MONITORING, AND PERSONALIZED MANAGEMENT OF CARDIOVASCULAR CONDITIONS
• 7.4 MENTAL HEALTH & BEHAVIORAL HEALTH
  • 7.4.1 IMPROVING ACCESSIBILITY TO MENTAL HEALTH SERVICES, ESPECIALLY IN UNDERSERVED REGIONS
• 7.5 RESPIRATORY DISORDERS
  • 7.5.1 ENABLING REAL-TIME MONITORING OF LUNG FUNCTION, MEDICATION ADHERENCE, AND OXYGEN LEVELS
• 7.6 LIFESTYLE & WELLNESS IMPROVEMENT
  • 7.6.1 EXPANDING ACCESS AND PERSONALIZING CARE IN MENTAL & BEHAVIORAL HEALTH THROUGH DIGITAL HEALTH
• 7.7 NEUROLOGY
  • 7.7.1 ADVANCING NEUROLOGICAL CARE WITH DIGITAL HEALTH INNOVATIONS
• 7.8 MUSCULOSKELETAL DISORDERS/PAIN MANAGEMENT
  • 7.8.1 ACCELERATING INNOVATION IN HANDHELD & PORTABLE DEVICES TO BOOST MARKET GROWTH
• 7.9 ONCOLOGY
  • 7.9.1 ADOPTION OF AI IN REMOTE PATIENT MONITORING (RPM) TO LEAD TO ITS EMERGING AS PROMISING SOLUTION TO SUPPORT PERSONALIZED CARE
• 7.10 WOMEN'S HEALTH & REPRODUCTIVE HEALTH
  • 7.10.1 ENHANCING PREVENTIVE CARE, EMPOWERING WOMEN WITH SELF-MANAGEMENT TOOLS, AND STRENGTHENING OUTCOMES IN REPRODUCTIVE AND MATERNAL HEALTH
• 7.11 OTHER DISEASES

8 DIGITAL HEALTH MARKET, BY USE CASE

• 8.1 INTRODUCTION
• 8.2 PREVENTIVE CARE & WELLNESS
  • 8.2.1 DRIVING PROACTIVE HEALTH MANAGEMENT THROUGH DIGITAL INNOVATION
• 8.3 DIAGNOSIS
  • 8.3.1 ADVANCING DIAGNOSIS THROUGH AI-POWERED SYMPTOM CHECKING AND EARLY DETECTION
• 8.4 TREATMENT
  • 8.4.1 FEEDING REAL-TIME DATA TO HEALTHCARE PROVIDERS, ALLOWING TREATMENT ADJUSTMENTS AND PROACTIVE INTERVENTIONS
• 8.5 PATIENT MONITORING
  • 8.5.1 SHIFT TOWARD PERSONALIZED, SCALABLE, AND PREVENTIVE CARE
• 8.6 REHABILITATION & RECOVERY
  • 8.6.1 PARTICULARLY IMPACTFUL IN POST-SURGICAL CARE, NEUROLOGICAL REHABILITATION, STROKE RECOVERY, AND MUSCULOSKELETAL THERAPY
• 8.7 OTHER USE CASES

9 DIGITAL HEALTH MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HEALTHCARE PROVIDERS
  • 9.2.1 HOSPITALS
    • 9.2.1.1 Rise in demand for high-quality care and government support to encourage digital health adoption in hospitals
  • 9.2.2 CLINICS & OTHER OUTPATIENT SETTINGS
    • 9.2.2.1 Increase in demand for cost-effective care and postoperative monitoring to drive digital health adoption in outpatient settings
  • 9.2.3 OTHER HEALTHCARE PROVIDERS
• 9.3 HEALTHCARE PAYERS
  • 9.3.1 PUBLIC PAYERS
    • 9.3.1.1 Driving population health and value-based care through digital innovation
  • 9.3.2 PRIVATE PAYERS
    • 9.3.2.1 Personalized benefit designs, value-based provider contracting, and delivering consumer-centric experiences
• 9.4 PATIENTS & CONSUMERS
  • 9.4.1 AI AND WEARABLE DEVICES TO DRIVE GROWTH IN DIGITAL HEALTH FOR PERSONALIZED CARE AND ACCESSIBILITY
• 9.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDTECH COMPANIES
  • 9.5.1 PHARMACEUTICAL AND BIOTECH ADOPTION OF DIGITAL HEALTH TO ENHANCE DRUG DEVELOPMENT, PATIENT ENGAGEMENT, AND ADHERENCE
• 9.6 OTHER END USERS

10 DIGITAL HEALTH MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Integration of AI, data interoperability, and virtual-first care models to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Advancing health equity and access through digital infrastructure
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Innovation-focused policy framework and digital infrastructure expansion to support growth
  • 10.3.3 UK
    • 10.3.3.1 Increase in prevalence of chronic and lifestyle-related diseases and high penetration of wearables to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Government support for e-Health to propel market
  • 10.3.5 ITALY
    • 10.3.5.1 Digital transformation and integrated care to support market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Health system modernization and data-driven care to enable digital health growth in Spain
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 High burden of chronic diseases to fuel market growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Large geriatric population and strong push toward modernization to propel market
  • 10.4.4 INDIA
    • 10.4.4.1 Growing adoption of telemedicine and mounting pressure to reduce healthcare expenditure to drive market
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Telehealth and digital integration to drive growth in Australia's digital health market
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 AI, data ecosystems, and cross-sector synergy to power South Korea's digital health growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Government digitalization push and interoperability frameworks to catalyze market expansion
  • 10.5.3 MEXICO
    • 10.5.3.1 Government reforms, infrastructural expansion, and chronic disease burden to drive market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC
    • 10.6.2.1 AI leadership, virtual infrastructure, and policy alignment to power digital health growth in GCC
    • 10.6.2.2 Saudi Arabia
      • 10.6.2.2.1 Rapid digital health transformation to propel market in Saudi Arabia
    • 10.6.2.3 UAE
      • 10.6.2.3.1 UAE emerges as regional pioneer in digital healthcare innovation
    • 10.6.2.4 Rest of GCC
  • 10.6.3 SOUTH AFRICA
    • 10.6.3.1 Infrastructure expansion, youthful demographics, and innovation ecosystems to accelerate digital health growth
  • 10.6.4 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL HEALTH MARKET
• 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 BRAND/SOFTWARE COMPARISON
• 11.6 COMPANY VALUATION & FINANCIAL METRICS
  • 11.6.1 FINANCIAL METRICS
  • 11.6.2 COMPANY VALUATION
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT
  • 11.7.6 REGION FOOTPRINT
  • 11.7.7 OFFERING FOOTPRINT
  • 11.7.8 DISEASE FOOTPRINT
  • 11.7.9 USE CASE FOOTPRINT
  • 11.7.10 END USER FOOTPRINT
• 11.8 STARTUP/SME EVALUATION MATRIX, 2024
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 DYNAMIC COMPANIES
  • 11.8.3 RESPONSIVE COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of startups/SMEs
• 11.9 COMPETITIVE SCENARIO AND TRENDS
  • 11.9.1 PRODUCT LAUNCHES & APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 MEDTRONIC
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Other developments
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 ABBOTT
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches & approvals
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 DEXCOM, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & approvals
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 KONINKLIJKE PHILIPS N.V.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches & approvals
      • 12.1.4.3.2 Deals
      • 12.1.4.3.3 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 FITBIT, INC. (GOOGLE)
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches & approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 OMRON HEALTHCARE, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches & approvals
      • 12.1.6.3.2 Deals
  • 12.1.7 APPLE, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches & approvals
      • 12.1.7.3.2 Deals
  • 12.1.8 BOSTON SCIENTIFIC CORPORATION
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches & approvals
      • 12.1.8.3.2 Deals
  • 12.1.9 MASIMO
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches & approvals
      • 12.1.9.3.2 Deals
  • 12.1.10 TELADOC HEALTH, INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches & approvals
      • 12.1.10.3.2 Deals
  • 12.1.11 AMERICAN WELL
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches & approvals
      • 12.1.11.3.2 Deals
      • 12.1.11.3.3 Other developments
  • 12.1.12 HIMS & HERS HEALTH, INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches & approvals
      • 12.1.12.3.2 Deals
  • 12.1.13 HEADSPACE
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product launches & approvals
      • 12.1.13.3.2 Deals
  • 12.1.14 NOOM, INC.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches & approvals
      • 12.1.14.3.2 Deals
  • 12.1.15 CEREBRAL INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches & approvals
      • 12.1.15.3.2 Deals
  • 12.1.16 EPIC SYSTEMS CORPORATION
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches & approvals
      • 12.1.16.3.2 Deals
  • 12.1.17 OMADA HEALTH INC.
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product launches & approvals
      • 12.1.17.3.2 Deals
  • 12.1.18 ORACLE
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches & approvals
      • 12.1.18.3.2 Deals
  • 12.1.19 CLICK THERAPEUTICS, INC.
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Product launches & approvals
      • 12.1.19.3.2 Deals
  • 12.1.20 WELLDOC, INC.
    • 12.1.20.1 Business overview
    • 12.1.20.2 Products offered
    • 12.1.20.3 Recent developments
      • 12.1.20.3.1 Product launches & approvals
      • 12.1.20.3.2 Deals
  • 12.1.21 EVERLYWELL
    • 12.1.21.1 Business overview
    • 12.1.21.2 Products offered
    • 12.1.21.3 Recent developments
      • 12.1.21.3.1 Product launches & approvals
      • 12.1.21.3.2 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 TRUDOC HEALTHCARE LLC
  • 12.2.2 CARESIMPLE INC.
  • 12.2.3 VIVALNK, INC.
  • 12.2.4 BIOBEAT
  • 12.2.5 VIRTUAL THERAPEUTICS CORP.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS